what we do?

Rooted in science

sourced worldwide

LianBio is a Chinese company focused on bringing paradigm-shifting medicines to patients.

arrow-btn

Scroll to see more

arrow-btn

intro

Our Mission

LianBio’s mission is to catalyze the development and accelerate availability of paradigm-shifting medicines to patients in China and major Asian markets through partnerships that provide access to the best science-driven therapeutic discoveries.

Learn More

Pipeline

Our Future

We are focused on building out a pipeline based on disease relevance to our target markets and the ability to impact patients with transformative mechanisms and precision-based therapeutics. We select programs with a strong scientific basis and clinical data and collaborate with world-class partners across a diverse array of therapeutic areas.

Stay up to date

News & Events

August 11, 2020

MyoKardia and LianBio Form Strategic Partnership to Develop and Commercialize Mavacamten Together in Greater China

arrow-btn

August 11, 2020

BridgeBio Pharma Expands Reach Into China and Other Major Asian Markets Through Strategic Collaboration With Perceptive Advisors-Founded Company, LianBio

arrow-btn

August 11, 2020

Perceptive Advisors Launches LianBio with Multiple Strategic Alliances and Establishes Operating Platform

arrow-btn
See All

We are here for you

Contact Us

Office Addresses

Shanghai Office
9th Floor, Kerry Parkside, 1155 Fangdian Road
Unit 901-902
Shanghai, PRC 201204

New Jersey Office
103 Carnegie Center Drive
Suite 215
Princeton, NJ 08540